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I In nt tr ro od du uc ct ti io on n Molecular diagnostics of cancer predisposition is very important for the medical treatment of the patient and persons belonging to the high risk group. Molecular studies enable the detection of mutation carriers and release from unreasonable stress of persons from the group with increased risk of cancer occurrence. The mutation spectrums in the genes predisposing to colorectal cancer in the Polish population have been described [1] [2] [3] [4] . In the present work we focused on recurrent mutations of the APC gene causing FAP [5] .
Familial adenomatous polyposis (FAP) is characterized by the appearance of numerous polyps in the large intestine. Untreated polyps lead to the development of colorectal cancer before age of 50 years. FAP is a genetically determined disorder, inherited in an autosomal dominant manner. The correlation between mutations of the APC gene and the occurrence of familial adenomatous polyposis was described in 1991 [1, 2] and since then, mutations of the APC gene have been investigated in research centres leading to identification of various mutation types. APC gene mutations arise de novo in 1 per 10,000 newborns. The APC gene is localized on chromosome 5q21 and consists of 21 exons. Mutations of the APC gene, in most cases, are small deletions or insertions with the most frequent mutations, in the greater part of the described populations, being the AAAGA deletion at codon 1309 and the ACAAA deletion at codon 1061. 
P Pa at ti ie en nt ts s
The mutations and age of onset are presented in Table 1 . Two of them were localized in exon 11 and the remaining six in the 3' part of exon 15. The most frequent mutation, 3927-3931delAAAGA, occurred in twenty-eight families (10%); the second one was 3183-3187delACAAA, occurring in eight families (2.8%); and the third most frequent mutation was 3202-3205delTCAA, detected in 5 families (1.7%). In our FAP patients Y500X occurred in four families (1.4%) while Q978X was detected in three families. Each of the remaining four types of mutation occurred in two families and the frequencies of these mutations were below one percent.
In gene. The most important mutation of the APC gene is 3927-3931delAAAGA. The frequency of these mutations varies depending on populations. The mutation reports describe the frequency of this mutation from 0% in northwest Spain, 2.4% in the Australian population, 5% in Dutch, 7% in Israeli to 16% in the group of Italian FAP patients [6] [7] [8] [9] . The second most frequent mutation, 3183-3187delACAAA, is reported with frequency ranging from 0% in northwest Spain, 1.5% in Israeli populations to 8.4% in Australia [6] [7] [8] [9] . A study of over 100 Dutch families revealed equal frequency of those two most frequent mutations (3927-3931delAAAGA and 3183-3187delACAAA) [10] . The largest studies of APC gene mutations were performed on a German population [11, 12] . The latest published report in 2005 involved the analysis of over 1000 patients. In comparison to this study, the representative study of mutation frequency in the neighbouring population indicated two times higher frequency of 3927-3931delAAAGA, whereas a difference in frequency of 3183-3187del-ACAAA was not observed (Germany 3.8%, Poland 2.7%). The frequency of 3202-3205delTCAA was equal (1.7%) in both populations. In worldwide comparison differences in the frequency of mutations were observed. The Polish population of FAP patients belongs to the group where 3927-3931delAAAGA occurred with higher frequency, whereas the frequency of mutation 3183-3187del-ACAAA occurred with medium frequency in comparison with other populations. The two recurrent mutations localized on exon 11 were observed only in the Polish population. In our two unrelated families with 1490-1491insT brain tumours were observed. Additionally in one family desmoid tumours occurred [10, 13] . Another mutation (Q978X) did not occur with higher frequency as described for other populations [14] . In our FAP patient group Q283X, which occurs with frequency of 4.5% in UK FAP patients, was not observed [13] . Recurrent mutations occurred in 54 Polish FAP families. Screening for these mutations permitted us to diagnose 19% of all families in our population but eight types of mutations constitute 43.5% of all our diagnosed families. The mutation study in our population should involve these eight mutations to improve molecular diagnostics of the APC gene.
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